// App-Quantinova.ai

592 : Tumor infiltrating lymphocytes and hydrophobic amino acid changes in HER2-positive metastatic breast cancer.

Researchers

Presenter

  • Vassiliki Kotoula

Principal Investigators

  • Zoi Alexopoulou

  • Vasilios Karavasilis

  • Athanasios Kotsakis

  • Dimitrios Dionysopoulos

  • Christos Christodoulou

  • Eleftheria Tsolaki

  • Mattheos Bobos

  • Elpida Charalambous

  • George E. Pentheroudakis

  • Thomas Makatsoris

  • Sofia Chrisafi

  • Dimitrios G. Pectasides

  • Amanda Psyrri

  • Pavlos Papakostas

  • Evangelia Razis

  • Dimitris Bafaloukos

  • Vasileios Georgoulias

  • George Fountzilas

Medical Centers

  • Hellenic Cooperative Oncology Group (HeCOG), Athens, Greece

  • The University of New South Wales, NSW, Australia

  • Health Data Specialists Ltd, Athens, Greece

  • Laboratory of Tumor Cell Biology, School of Medicine, University of Crete, Heraklion, Greece

Locations

  • Greece

  • Australia

Companies

  • Health Data Speciali

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

Biomarkers

  • Human epidermal growth factor receptor 2

  • ZFP36 Ring Finger Protein Like 1

Drug/Treatment

  • Trastuzumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved